Organization

Boston Children's Hospital

49 clinical trials

9 abstracts

Abstract
A multicenter cooperative group study of late effects after high-risk neuroblastoma: COG ALTE15N2—LEAHRN study.
Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, St. Jude Children's Research Hospital, Children's Oncology Group Statistics and Data Center, University of Florida, Children's Hospital Los Angeles Department of Pediatrics,
Abstract
Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.
Org: Children’s Hospital of Philadelphia, University of Pennsylvania, Children's Oncology Group Statistics and Data Center, University of Florida, CanSino Biologics, Dana Farber Cancer Institute, Boston, MA,
Abstract
Carvedilol for prevention of heart failure in anthracycline-exposed survivors of childhood cancer: Results from COG ALTE1621.
Org: City of Hope National Medical Center, City of Hope Comprehensive Cancer Center, Boston Children's Hospital, Boston Children's Hospital and Dana-Farber Cancer Institute, St. Jude Children's Research Hospital,
Abstract
Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.
Org: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Children's Hospital of Philidelphia, St. Louis Children's Hospital, University of Florida-Health Cancer Center, Orlando Health, Orlando, FL, Massachusetts General Hospital,
Abstract
Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.
Org: Children's Hospital Colorado, Aurora, CO, Children's Oncology Group Statistics and Data Center, University of Florida, Baylor College of Medicine, Children's Hospital of Philadelphia, Roswell Park Cancer Institute Department of Cancer Prevention and Population Sciences,
Abstract
Molecular characterization of patients with localized Ewing sarcoma targeting discrete prognostic groups: A report from the Children’s Oncology Group.
Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Children's Oncology Group Statistics and Data Center, University of Florida, Cleveland Clinic Lerner College of Medicine,
Clinical trial
Genetics of Epilepsy and Related Disorders
Status: Recruiting, Estimated PCD: 2030-12-01
Abstract
A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).
Org: Dana-Farber Cancer Institute, DFCI/PCC Fellowship Program - Attendings, Massachusetts General Hospital, Kite Pharma, Division of Neuroradiology,
Abstract
Outcome of children and young adults with localized extremity rhabdomyosarcoma treated on Children's Oncology Group trials.
Org: CancerCare Manitoba, University of Florida-Health Cancer Center, Orlando Health, Orlando, FL, The Ohio State University James Cancer Center, H. Lee Moffitt Cancer Center and Research Institute, Cincinnati Children's Hospital Medical Center,
Clinical trial
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Status: Not yet recruiting, Estimated PCD: 2028-05-01
Clinical trial
A Prospective Controlled Treatment Trial for Post-Traumatic Headaches
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Abstract
Statistical fragility of findings from randomized phase 3 trials in pediatric oncology.
Org: Boston Children's Hospital, Boston Children’s Hospital, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
Clinical trial
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
Status: Active (not recruiting), Estimated PCD: 2023-12-01
Clinical trial
Effect of Dexmedetomidine of Gastrointestinal Motility
Status: Completed, Estimated PCD: 2022-11-15
Clinical trial
Low Dose IL-2 for the Treatment of Crohn's Disease
Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Controlling and Preventing Asthma Progression and Severity in Kids
Status: Active (not recruiting), Estimated PCD: 2028-01-31
Clinical trial
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
Status: Completed, Estimated PCD: 2022-08-29
Clinical trial
Genetic Studies of Strabismus, Nystagmus, and Associated Disorders
Status: Recruiting, Estimated PCD: 2026-12-01
Clinical trial
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management
Status: Completed, Estimated PCD: 2022-01-22
Clinical trial
Quadratus Lumborum vs Erector Spinae Supplementary Blocks With Lumbar Plexus Blocks for Hip PAO
Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Lidocaine Versus Bupivacaine in Orthognathic Surgery: A Randomized Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
Status: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
Status: Not yet recruiting, Estimated PCD: 2026-10-01
Clinical trial
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)
Status: Not yet recruiting, Estimated PCD: 2024-04-01
Clinical trial
Biomarkers of ADHD Treatment Response
Status: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
Status: Active (not recruiting), Estimated PCD: 2022-12-19
Clinical trial
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Status: , Estimated PCD: 2023-12-01
Clinical trial
Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
Status: Terminated, Estimated PCD: 2013-08-01
Clinical trial
Phase 2 Study of Omalizumab in Oral Peanut Desensitization
Status: Completed, Estimated PCD: 2015-10-01
Clinical trial
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine
Status: Not yet recruiting, Estimated PCD: 2026-08-31